UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characterisation of Drug Delivery Efficacy Using Microstructure-Assisted Application of a Range of APIs

Pharmaceutics, 2020-12, Vol.12 (12), p.1213

2020

Volltextzugriff (PDF)

Demographic and Clinical Characteristics of Patients With Type 2 Diabetes Mellitus Initiating Dipeptidyl Peptidase 4 Inhibitors: A Retrospective Study of UK General Practice

Clinical therapeutics, 2016-08, Vol.38 (8), p.1825-1832.e15

2016

Volltextzugriff (PDF)

Corrigendum to ‘Demographic and clinical characteristics of type 2 diabetes mellitus patients initiating dipeptidyl peptidase-4 inhibitors - a retrospective study of UK general practice’

Clinical therapeutics, 2017-06, Vol.39 (6), p.1266-1270

2017

Volltextzugriff (PDF)

Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double‐blind, placebo‐controlled, rising‐dose trial

BJU international, 2008-11, Vol.102 (9), p.1120-1127

2008

Volltextzugriff (PDF)

Corrigendum to ‘Demographic and Clinical Characteristics of Type 2 Diabetes Mellitus Patients Initiating Dipeptidyl Peptidase-4 Inhibitors - A Retrospective Study of UK General Practice’ Clin Ther 2016;8:1825–1832.e15

Clinical therapeutics, 2017-03, Vol.39 (3), p.662-662.e15

2017

Volltextzugriff (PDF)

Treatment Outcomes in the STAR Study: A Subanalysis of Solifenacin 5 mg and Tolterodine ER 4 mg

European urology, 2007-10, Vol.52 (4), p.1195-1203

2007

Volltextzugriff (PDF)

Treatment patterns and clinical outcomes of newly diagnosed locally advanced head and neck squamous cell carcinoma (LA HNSCC): A retrospective cohort analysis of national real-world data in England

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e18075-e18075

2023

Volltextzugriff (PDF)

Telomerase activity in human breast cancer and benign breast lesions: Diagnostic applications in clinical specimens, including fine needle aspirates

International journal of cancer, 1996-08, Vol.69 (4), p.301-306

1996

Volltextzugriff (PDF)

A randomized double‐blind placebo‐controlled multicentre study to explore the efficacy and safety of tamsulosin and tolterodine in women with overactive bladder syndrome

BJU international, 2007-10, Vol.100 (4), p.840-845

2007

Volltextzugriff (PDF)

Re-evaluating the PCSK9 guidelines for low-density lipoprotein cholesterol targets: weighing the benefits against the risks

Cardiovascular Prevention and Pharmacotherapy, 2024-07, Vol.6 (3), p.85-91

2024

Volltextzugriff (PDF)

Efficacy of simplified bladder training in patients with overactive bladder receiving a solifenacin flexible‐dose regimen: results from a randomized study

BJU international, 2010-04, Vol.105 (8), p.1126-1135

2010

Volltextzugriff (PDF)

Exploratory pilot study assessing the risk of cognitive impairment or sedation in the elderly following single doses of solifenacin 10 mg

Expert opinion on drug safety, 2009-11, Vol.8 (6), p.615-626

2009

Volltextzugriff (PDF)

Elevated Interleukin-6 (IL-6) Levels with Ig (G & M) Antibodies in the Recovery Phase of Patients with COVID-19: Indication of Cytokine Storm and Re-infection

Journal of Cellular Signaling, 2024, Vol.5 (4), p.176-182

2024

Volltextzugriff (PDF)

Agreement of the Point of Care Test (POCT) Boditech iCHROMA™ Covid-19 IgG Antibody Assay with the Abbott Architect SARSCoV- 2 IgG Antibody Assay

Annals of Immunology & Immunotherapy, 2020, Vol.2 (2)

Bolodeoku, John

2020

Volltextzugriff (PDF)

Comparison of the point of care test (POCT), i-CHROMA™ human chorionic gonadotrophin (HCG), leutinzing hormone (LH) and follicle stimulating hormone (FSH) methods with the other laboratory methods in the Randox International Quality Assessment Scheme (RIQAS)

Clinical obstetrics, gynecology and reproductive medicine, 2017, Vol.3 (4)

2017

Volltextzugriff (PDF)

A cost-utility analysis of once daily solifenacin compared to tolterodine in the treatment of overactive bladder syndrome

Current medical research and opinion, 2008-08, Vol.24 (8), p.2173-2179

2008

Volltextzugriff (PDF)

An Evaluation of the Novel i-CHROMA™ Point-of-Care Testing (POCT) Method for the Analysis of Prostate-Specific Antigen (PSA) in Serum

Biomedical Journal of Scientific & Technical Research, 2018-10, Vol.9 (4)

Bolodeoku, John

2018

Volltextzugriff (PDF)

An Evaluation of the Point-of-Care Test i-CHROMA Prostate-Specific Antigen Method for Screening in the Community

Point of care, 2017-06, Vol.16 (2), p.93-96

2017

Volltextzugriff (PDF)

An Assessment of Automated Vitamin D Measurement Methods Including a Point-of-Care Testing Method, I-CHROMA™ Using the Randox International Quality Assurance Scheme (Riqas)

Biomedical Journal of Scientific & Technical Research, 2018-04, Vol.3 (4)

Bolodeoku, John

2018

Volltextzugriff (PDF)

A Survey of the Awareness, Knowledge, and Experience of Point-of-Care Devices of Doctors in Nigeria

Point of care, 2016-03, Vol.15 (1), p.22-25

2016

Volltextzugriff (PDF)

Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine

Cancer, 1997-01, Vol.79 (2), p.362-369

1997

Volltextzugriff (PDF)

The Impact of Tamsulosin Oral Controlled Absorption System (OCAS) on Nocturia and the Quality of Sleep: Preliminary Results of a Pilot Study

European urology supplements : official journal of the European Association of Urology, 2005-02, Vol.4 (2), p.61-68

2005

Volltextzugriff (PDF)

A correlation and red, amber, green (RAG) analysis of Boditech i-CHROMA™ Prostate Specific Antigen (PSA) Point of Care Test (POCT) Method and Roche PSA laboratory methods

Journal of Global Medicine, 2023-11, Vol.3 (1), p.e113

2023

Volltextzugriff (PDF)

Progressive loss of CD44 gene expression in invasive bladder cancer

The American journal of pathology, 1996-09, Vol.149 (3), p.873-882

1996

Volltextzugriff (PDF)

Corrigendum to: “Treatment Outcomes in the STAR Study: A Subanalysis of Solifenacin 5 mg and Tolterodine ER 4 mg” [Eur Urol 2007;52:1195–1203]

European urology, 2008-08, Vol.54 (2), p.481-481

2008

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(38)
Dissertationen
(1)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Humans
(17)
Biological And Medical Sciences
(11)
Female
(11)
Medical Sciences
(11)
Aged
(6)
Male
(6)
Middle Aged
(6)
Oncology
(6)
Nephrology. Urinary Tract Diseases
(5)
Overactive Bladder
(5)
Solifenacin
(5)
Solifenacin Succinate
(5)
Urinary Tract. Prostate Gland
(5)
Urology & Nephrology
(5)
Double-Blind Method
(4)
Muscarinic Antagonists - Therapeutic Use
(4)
Treatment Outcome
(4)
Urinary Bladder, Overactive - Drug Therapy
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Characterisation of Drug Delivery Efficacy Using Microstructure-Assisted Application of a Range of APIs

Demographic and Clinical Characteristics of Patients With Type 2 Diabetes Mellitus Initiating Dipeptidyl Peptidase 4 Inhibitors: A Retrospective Study of UK General Practice

Corrigendum to ‘Demographic and clinical characteristics of type 2 diabetes mellitus patients initiating dipeptidyl peptidase-4 inhibitors - a retrospective study of UK general practice’

Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double‐blind, placebo‐controlled, rising‐dose trial

Corrigendum to ‘Demographic and Clinical Characteristics of Type 2 Diabetes Mellitus Patients Initiating Dipeptidyl Peptidase-4 Inhibitors - A Retrospective Study of UK General Practice’ Clin Ther 2016;8:1825–1832.e15

Treatment Outcomes in the STAR Study: A Subanalysis of Solifenacin 5 mg and Tolterodine ER 4 mg

Treatment patterns and clinical outcomes of newly diagnosed locally advanced head and neck squamous cell carcinoma (LA HNSCC): A retrospective cohort analysis of national real-world data in England

Telomerase activity in human breast cancer and benign breast lesions: Diagnostic applications in clinical specimens, including fine needle aspirates

A randomized double‐blind placebo‐controlled multicentre study to explore the efficacy and safety of tamsulosin and tolterodine in women with overactive bladder syndrome

Re-evaluating the PCSK9 guidelines for low-density lipoprotein cholesterol targets: weighing the benefits against the risks

Efficacy of simplified bladder training in patients with overactive bladder receiving a solifenacin flexible‐dose regimen: results from a randomized study

Exploratory pilot study assessing the risk of cognitive impairment or sedation in the elderly following single doses of solifenacin 10 mg

Elevated Interleukin-6 (IL-6) Levels with Ig (G & M) Antibodies in the Recovery Phase of Patients with COVID-19: Indication of Cytokine Storm and Re-infection

Agreement of the Point of Care Test (POCT) Boditech iCHROMA™ Covid-19 IgG Antibody Assay with the Abbott Architect SARSCoV- 2 IgG Antibody Assay

Comparison of the point of care test (POCT), i-CHROMA™ human chorionic gonadotrophin (HCG), leutinzing hormone (LH) and follicle stimulating hormone (FSH) methods with the other laboratory methods in the Randox International Quality Assessment Scheme (RIQAS)

A cost-utility analysis of once daily solifenacin compared to tolterodine in the treatment of overactive bladder syndrome

An Evaluation of the Novel i-CHROMA™ Point-of-Care Testing (POCT) Method for the Analysis of Prostate-Specific Antigen (PSA) in Serum

An Evaluation of the Point-of-Care Test i-CHROMA Prostate-Specific Antigen Method for Screening in the Community

An Assessment of Automated Vitamin D Measurement Methods Including a Point-of-Care Testing Method, I-CHROMA™ Using the Randox International Quality Assurance Scheme (Riqas)

A Survey of the Awareness, Knowledge, and Experience of Point-of-Care Devices of Doctors in Nigeria

Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine

The Impact of Tamsulosin Oral Controlled Absorption System (OCAS) on Nocturia and the Quality of Sleep: Preliminary Results of a Pilot Study

A correlation and red, amber, green (RAG) analysis of Boditech i-CHROMA™ Prostate Specific Antigen (PSA) Point of Care Test (POCT) Method and Roche PSA laboratory methods

Progressive loss of CD44 gene expression in invasive bladder cancer

Corrigendum to: “Treatment Outcomes in the STAR Study: A Subanalysis of Solifenacin 5 mg and Tolterodine ER 4 mg” [Eur Urol 2007;52:1195–1203]

Suchergebnisse filtern